Literature DB >> 26170955

Experimental study of temperature-sensitive chitosan/β-glycerophosphate embolic material in embolizing the basicranial rete mirabile in swines.

Xianbin Ning1, Changfu Zhao1, Jinfeng Pang1, Zhaoyi Ding1, Yubo Wang2, Kan Xu2, Hao Chen2, Bingwei Li2, Q I Luo2.   

Abstract

The aim of the present study was to evaluate the feasibility of the non-adhesive temperature-sensitive liquid embolic material, chitosan/β-glycerophosphate (C/GP), in embolizing the basicranial rete mirabile (REM) in a swine model of cerebral arteriovenous malformation (cAVM). A total of 24 domestic swines were used as the experimental animals, among which 12 pigs underwent direct embolization of one side of the REM, while the other 12 pigs underwent embolization of the bilateral REM following anastomosis of the carotid artery and jugular vein. A super-selective microcatheter was introduced into the REM during the embolization procedure, and the C/GP hydrogel was injected until an image of the REM disappeared in the angiography examination. Further angiography examinations were performed after 2 and 6 weeks, and histological examination of the REM was performed after 6 weeks. Of the 24 domestic swines, 23 cases underwent successful thrombosis. Convulsions occurred in one case and that pig died during the embolization procedure. Following embolization, the angiography observations revealed that the embolized REM was no longer able to be developed, and adhesion of the microcatheter tip with the embolic agent did not occur. In addition, no apparent revascularization was observed in the angiography examinations performed at weeks 2 and 6. Therefore, the current preliminary study indicated that use of the non-adhesive temperature-sensitive embolic material was feasible for the embolization of cAVM; thus, C/GP may be used as an ideal embolic material for the treatment of cAVM.

Entities:  

Keywords:  basicranial rete mirabile; cerebral arteriovenous malformations; chitosan/β-glycerophosphate; embolism; intervention

Year:  2015        PMID: 26170955      PMCID: PMC4486800          DOI: 10.3892/etm.2015.2479

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  27 in total

1.  Early results of CyberKnife radiosurgery for arteriovenous malformations.

Authors:  Federico Colombo; Carlo Cavedon; Leopoldo Casentini; Paolo Francescon; Francesco Causin; Vittore Pinna
Journal:  J Neurosurg       Date:  2009-10       Impact factor: 5.115

Review 2.  Endovascular treatment of intracranial arteriovenous malformation.

Authors:  Dorothea Strozyk; Raul G Nogueira; Sean D Lavine
Journal:  Neurosurg Clin N Am       Date:  2009-10       Impact factor: 2.509

3.  In vitro insulin release from thermosensitive chitosan hydrogel.

Authors:  Elham Khodaverdi; Mohsen Tafaghodi; Fariba Ganji; Khalil Abnoos; Hanie Naghizadeh
Journal:  AAPS PharmSciTech       Date:  2012-03-06       Impact factor: 3.246

4.  Aberrant angiogenic characteristics of human brain arteriovenous malformation endothelial cells.

Authors:  Mark N Jabbour; James B Elder; Christian G Samuelson; Shabnam Khashabi; Florence M Hofman; Steven L Giannotta; Charles Y Liu
Journal:  Neurosurgery       Date:  2009-01       Impact factor: 4.654

5.  A regulated delivery system for inner ear drug application.

Authors:  Shayanne A Lajud; Zhao Han; Fang-Lu Chi; Rende Gu; Danish A Nagda; Orysia Bezpalko; Samudra Sanyal; Andres Bur; Ziying Han; Bert W O'Malley; Daqing Li
Journal:  J Control Release       Date:  2013-01-08       Impact factor: 9.776

6.  Ten-year detection rate of brain arteriovenous malformations in a large, multiethnic, defined population.

Authors:  Rodney A Gabriel; Helen Kim; Stephen Sidney; Charles E McCulloch; Vineeta Singh; S Claiborne Johnston; Nerissa U Ko; Achal S Achrol; Jonathan G Zaroff; William L Young
Journal:  Stroke       Date:  2009-11-19       Impact factor: 7.914

7.  Nonadhesive liquid embolic agent for cerebral arteriovenous malformations: preliminary histopathological studies in swine rete mirabile.

Authors:  Y Murayama; F Viñuela; A Ulhoa; Y Akiba; G R Duckwiler; Y P Gobin; H V Vinters; R J Greff
Journal:  Neurosurgery       Date:  1998-11       Impact factor: 4.654

8.  Histopathological changes in brain arteriovenous malformations after embolization using Onyx or N-butyl cyanoacrylate. Laboratory investigation.

Authors:  Sabareesh Kumar Natarajan; Donald Born; Basavaraj Ghodke; Gavin W Britz; Laligam N Sekhar
Journal:  J Neurosurg       Date:  2009-07       Impact factor: 5.115

9.  Characterization of the interaction between chitosan and inorganic sodium phosphates by means of rheological and optical microscopy studies.

Authors:  Luca Casettari; Marco Cespi; Giovanni Filippo Palmieri; Giulia Bonacucina
Journal:  Carbohydr Polym       Date:  2012-08-30       Impact factor: 9.381

10.  Clinical and morphological determinants of focal neurological deficits in patients with unruptured brain arteriovenous malformation.

Authors:  J H Choi; H Mast; A Hartmann; R S Marshall; J Pile-Spellman; J P Mohr; C Stapf
Journal:  J Neurol Sci       Date:  2009-09-03       Impact factor: 3.181

View more
  2 in total

Review 1.  Advances in Biomaterials and Technologies for Vascular Embolization.

Authors:  Jingjie Hu; Hassan Albadawi; Brian W Chong; Amy R Deipolyi; Rahul A Sheth; Ali Khademhosseini; Rahmi Oklu
Journal:  Adv Mater       Date:  2019-06-06       Impact factor: 30.849

2.  Imaging artifacts of Onyx and PHIL on conventional CT, cone-beam CT and MRI in an animal model.

Authors:  Dominik F Vollherbst; Ruth Otto; Thuy Do; Hans U Kauczor; Martin Bendszus; Christof M Sommer; Markus A Möhlenbruch
Journal:  Interv Neuroradiol       Date:  2018-07-04       Impact factor: 1.610

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.